Merck & Co. stock heads into the open after a modest gain
Published on 09/15/2026 at 08:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Merck & Co. stock closed at USD 144.02 on the New York Stock Exchange on September 14, 2026, showing a modest daily gain from the previous session. The move came as US equities broadly softened, with Merck & Co. stock holding up better than the large-cap benchmark.
September 14, 2026 in numbers
Merck & Co., Inc. (ISIN US58933Y1055, NYSE: MRK) ended the September 14, 2026 session on its New York home market with a close of USD 144.02, within the day's intraday trading range and inside its current 52-week corridor, according to exchange data. The stock's percent change on the day was slightly positive, contrasting with the S&P 500, which fell 37.00 points, or 0.5%, to finish at 7,619.98 on September 14, 2026 per market index data. As Hdfcsky reported on September 14, 2026, investors rotated toward income-oriented healthcare names, and Merck was cited with a gain of 0.63% during the regular session. Per closing data, Merck & Co., Inc. stock traded between its intraday low and high on September 14, 2026 with volume consistent with recent averages, and the positive finish left the shares above the level implied by the latest ex-dividend reference.
Ex-dividend and sector signals today
Today, September 15, 2026, Merck is due to trade ex-dividend for its latest quarterly cash payout, with a dividend of USD 0.85 per share referenced against the USD 144.02 stock level in recent dividend overviews. As Kurzy.cz highlighted on September 14, 2026, Merck appears among this week's US dividend names with its quarterly distribution scheduled around September 15, 2026. In addition, commentary from the Morgan Stanley healthcare conference has kept attention on Merck's pipeline and capital allocation plans; Investing.com reported on September 14, 2026 that Merck's chief executive discussed ongoing pipeline progress at the event. Alongside these company-specific factors, broader US economic and Federal Reserve expectations, noted in dividend and macro commentary, may influence health-care valuations today as Merck & Co. stock opens ex-dividend within a market still focused on rates and income-oriented sectors.
